SAN JOSE, Calif.--(BUSINESS WIRE)--While West Nile virus (WNV) has had significant outbreaks throughout the world since it was first identified, commercially available assay kits for the detection of WNV protease inhibitors had not been developed until now. With the SensoLyte™ series of WNV Protease Assay Kits AnaSpec, a worldwide provider of integrated proteomics solutions, has introduced the industry’s first commercially available assay kits for the detection of WNV protease NS3 inhibitors.
